Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation

Critical Care Medicine

Volumn 37, Issue 3, 2009, Pages 975-979

  Spiel, Alexander O ^a   Frossard, Martin ^a   Mayr, Florian B ^a,b   Kliegel, Andreas ^a   Janata, Andreas ^a   Uray, Thomas ^a   Wandaller, Cosima ^a   Sterz, Fritz ^a   Jilma, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac arrest; Myocardial infarction; Platelet function; Von Willebrand factor

Indexed keywords

ADRENALIN; APYRASE; COLLAGEN; CREATININE; FIBRINOGEN; LACTIC ACID; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ASYSTOLE; BLOOD ANALYSIS; BODY TEMPERATURE; CARDIAC PATIENT; CLINICAL ASSESSMENT; COLLAPSE; COMPLETE HEART BLOCK; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMERGENCY WARD; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEMATOCRIT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QT PROLONGATION; RESUSCITATION; SHEAR RATE; SYSTEMIC CIRCULATION; TERTIARY HEALTH CARE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; VALVULAR HEART DISEASE; WOLFF PARKINSON WHITE SYNDROME; BLOOD; CORONARY ARTERY BLOOD FLOW; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; CORONARY CIRCULATION; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PROSPECTIVE STUDIES;

EID: 62849115121     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181962cb9     Document Type: Article

References (38)

1. Rea TD, Eisenberg MS, Becker LJ, et al: Temporal trends in sudden cardiac arrest: A 25-year emergency medical services perspective. Circulation 2003; 107:2780-2785
2. Weaver WD, Cobb LA, Hallstrom AP, et al: Factors influencing survival after out-of-hospital cardiac arrest. J Am Coll Cardiol 1986; 7:752-757
3. Bernard SA, Gray TW, Buist MD, et al: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563
4. Spaulding CM, Joly LM, Rosenberg A, et al: Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997; 336:1629-1633
5. Kuisma M, Alaspaa A: Out-of-hospital cardiac arrests of non-cardiac origin. Epidemiology and outcome. Eur Heart J 1997; 18:1122-1128
6. Lederer W, Lichtenberger C, Pechlaner C, et al: Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001; 50:71-76
7. Bottiger BW, Bode C, Kern S, et al: Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial. Lancet 2001; 357:1583-1585
8. Spohr F, Arntz HR, Bluhmki E, et al: International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: The Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest 2005; 35:315-323
9. Bottiger BW, Bohrer H, Boker T, et al: Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation - can reperfusion be impaired by platelet activation? Acta Anaesthesiol Scand 1996; 40:631-635
10. Gando S, Nanzaki S, Morimoto Y, et al: Alterations of soluble L- and P-selectins during cardiac arrest and CPR. Intensive Care Med 1999; 25:588-593
11. Bottiger BW, Motsch J, Braun V, et al: Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 2002; 30:2473-2480
12. Gando S, Kameue T, Nanzaki S, et al: Platelet activation with massive formation of thromboxane A2 during and after cardiopulmonary resuscitation. Intensive Care Med 1997; 23: 71-76
13. Tanahashi N, Fukuuchi Y, Tomita M, et al: Platelet adhesion to human brain microvascular endothelial cells in vitro. Observation with video-enhanced contrast microscopy. Neurosci Lett 1999; 274:199-202
14. Pluta R, Lossinsky AS, Walski M, et al: Platelet occlusion phenomenon after short- and long-term survival following complete cerebral ischemia in rats produced by cardiac arrest. J Hirnforsch 1994; 35:463-471
15. Frossard M, Fuchs I, Leitner JM, et al: Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004; 110:1392-1397
16. Campo G, Valgimigli M, Gemmati D, et al: Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: Insights into the STRATEGY Study. J Am Coll Cardiol 2006; 48:2178-2185
17. American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care; Part 7.5: Pos-tresuscitation Support. Circulation 2005; 112(Suppl I):IV-84-IV-88
18. Gallistl S, Muntean W, Leschnik B, et al: Longer aPTT values in healthy children than in adults: No single cause. Thromb Res 1997; 88:355-359
19. Jilma B: Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138:152-163
20. Ziegler S, Maca T, Alt E, et al: Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Platelets 2002; 13:493-497
21. Reiter RA, Mayr F, Blazicek H, et al: Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 2003; 102:4594-4599
22. Raman S, Jilma B: Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100. J Thromb Haemost 2004; 2:2278-2279
23. Homoncik M, Jilma B, Hergovich N, et al: Monitoring of aspirin (ASA) pharmacody-namics with the platelet function analyzer PFA-100. Thromb Haemost 2000; 83: 316-321
24. Edgren E, Hedstrand U, Kelsey S, et al: Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group. Lancet 1994; 343:1055-1059
25. Spiel AO, Gilbert JC, Jilma B: von Willebrand factor in cardiovascular disease: Focus on acute coronary syndromes. Circulation 2008; 117:1449-1459
26. Goto S, Sakai H, Ikeda Y, et al: Acute myocardial infarction plasma augments platelet thrombus growth in high shear rates. Lancet 1997; 349:543-544
27. Goto S, Ikeda Y, Murata M, et al: Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation 1992; 86:1859-1863
28. Blann AD: Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost 2006; 95: 49-55
29. Pernerstorfer T, Stohlawetz P, Kapiotis S, et al: Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF secretion in man. Atherosclerosis 2000; 148: 43-47
30. Geppert A, Zorn G, Delle-Karth G, et al: Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful car-diopulmonary resuscitation. Crit Care Med 2003; 31:805-811
31. Leo R, Pratico D, Iuliano L, et al: Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxy-genated. Circulation 1997; 95:885-891
32. Inbal A, Gurevitz O, Tamarin I, et al: Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Wille-brand factor, AR545C: In vitro and ex vivo inhibition of platelet function. Blood 1999; 94:1693-1700
33. Gilbert JC, DeFeo-Fraulini T, Hutabarat RM, et al: First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation 2007; 116:2678-2686
34. Maioli M, Bellandi F, Leoncini M, et al: Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial). J Am Coll Cardiol 2007; 49:1517-1524
35. Kern KB, Cragan D, Zuercher M, et al: Post resuscitation myocardial microcirculatory dysfunction is ameliorated with platelet glycoprotein IIb/IIIa inhibition. Circulation 2007; 116:II-630-II-631
36. Kotzailias N, Elwischger K, Sycha T, et al: Clopidogrel-induced platelet inhibition cannot be detected by the platelet function ana-lyzer-100 system in stroke patients. J Stroke Cerebrovasc Dis 2007; 16:199-202
37. Karger R, Donner-Banzhoff N, Muller HH, et al: Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systematic review and meta-analysis. Platelets 2007; 18:249-260
38. Goldstein JA, Butterfield MC, Ohnishi Y, et al: Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia. Circulation 1994; 90:139-147